PBH FY 2022 Earnings Report — Prestige Consumer Healthcare Inc. Revenue & Financial Results | Market Cap Arena

Prestige Consumer Healthcare Inc.PBH

FY 2022 Earnings

Reported May 6, 2022

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2022	Prior Q	FY 2021	QoQ Change	YoY Change
Revenue	$1.1B	—	$943M	—	15.2%
Op. Income	$330M	—	$297M	—	10.9%
Gross Margin	57.1%	—	58.0%	—	-0.9pp
Net Margin	18.9%	—	17.5%	—	1.4pp
EPS (Diluted)	$4.04	—	$3.25	—	24.3%
Free Cash Flow	$250M	—	$213M	—	17.3%

Revenue Flow

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$466M
GROSS PROFIT	$621M
R&D Expenses	$0
Selling & Marketing	$157M
General & Administrative	$107M
SG&A Expenses	$265M
Other Expenses	$26M
Operating Expenses	$291M
Cost & Expenses	$757M
OPERATING INCOME	$330M
Interest Income	$0
Interest Expense	$64M
Other Income/Expenses	-$67M
INCOME BEFORE TAX	$262M
Income Tax Expense	$57M
Net Income from Continuing Ops	$205M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$205M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$205M
D&A	$32M
EBIT	$327M
EBITDA	$359M
EPS	$4
EPS Diluted	$4

Income Statement

Item	Amount
REVENUE	$1.1B
Cost of Revenue	$466M
GROSS PROFIT	$621M
R&D Expenses	$0
Selling & Marketing	$157M
General & Administrative	$107M
SG&A Expenses	$265M
Other Expenses	$26M
Operating Expenses	$291M
Cost & Expenses	$757M
OPERATING INCOME	$330M
Interest Income	$0
Interest Expense	$64M
Other Income/Expenses	-$67M
INCOME BEFORE TAX	$262M
Income Tax Expense	$57M
Net Income from Continuing Ops	$205M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$205M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$205M
D&A	$32M
EBIT	$327M
EBITDA	$359M
EPS	$4
EPS Diluted	$4

Cash Flow Statement

Item	Amount
Net Income	$205M
Depreciation & Amortization	$32M
Stock-Based Compensation	$9M
Deferred Income Tax	$10M
Other Non-Cash Items	$14M
Change in Working Capital	-$11M
OPERATING CASH FLOW	$260M
Capital Expenditure	-$10M
Acquisitions (Net)	-$247M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$257M
Net Debt Issuance	-$6M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$2M
NET CASH FROM FINANCING	-$8M
FREE CASH FLOW	$250M
Net Change in Cash	-$5M

Balance Sheet

Item	Amount
Cash & Equivalents	$27M
Short-Term Investments	$0
Net Receivables	$139M
Inventory	$120M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$293M
PP&E (Net)	$99M
Goodwill	$579M
Intangible Assets	$2.7B
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$3M
TOTAL NON-CURRENT ASSETS	$3.4B
TOTAL ASSETS	$3.7B
Account Payables	$56M
Short-Term Debt	$0
Deferred Revenue	$0
Other Current Liabilities	$20M
TOTAL CURRENT LIABILITIES	$143M
Long-Term Debt	$1.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$445M
Other Non-Current Liabilities	$7M
TOTAL NON-CURRENT LIABILITIES	$1.9B
TOTAL LIABILITIES	$2.1B
Common Stock	$544.0K
Additional Paid-In Capital	$516M
Retained Earnings	$1.2B
Treasury Stock	-$134M
Accum. Other Comp. Income	-$19M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.6B
Minority Interest	$0
TOTAL EQUITY	$1.6B
TOTAL LIABILITIES & EQUITY	$3.7B
Total Debt	$1.5B
Net Debt	$1.5B